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A 56-year-old patient (male, former smoker) 
was admitted to a municipal hospital due to 
gradually increasing fatigue, exercise dyspnea, 
and chest pain persisting for 3 weeks. The new 
diagnosis of heart failure with reduced ejection 
fraction (HFrEF) was established, the standard 
treatment was applied, and the resolution of 
symptoms was observed. After a few days, 
a routine test for severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2) was 
positive. Seven days later, dyspnea and chest 
pain reappeared. The patient was transferred 
to the cardiology department dedicated to 
COVID-19 patients.
On admission to our department, a com-
puter tomography with pulmonary angiogram 
revealed bilateral, multifocal, ground-glass 
opacities in the lungs and no signs of pulmo-
nary embolism. Inflammatory markers and 
N-terminal pro-B-type natriuretic peptide 
levels were significantly increased, whereas 
the troponin level was in the normal range. 
The patient’s blood pressure was 86/60 mm 
Hg, and SpO2 was reduced to 89%. The electro-
cardiogram showed inverted T waves in leads 
V1–V6 without ST-segment depression or ele-
vation. The echocardiography revealed reduced 
ejection fraction (26%), severe hypokinesis of 
the anterior wall, and apical segments (with-
out any features of myocardial necrosis). Viral 
pneumonia with HFrEF was diagnosed. Mild 
symptoms of low cardiac output were observed 
during the first several days of hospitalization. 
Recurrent episodes of chest pain were also ob-
served over the next few days. Coronary angiog-
raphy was performed as soon as the circulatory 
system was stabilized, and the infection was 
under control [1]. The  coronary angiography 
revealed an occluded left anterior descending 
artery (LAD) in the proximal segment (Figure 
1A). The distal part of the LAD could be seen 
due to the presence of the collateral circulation 
from the right coronary artery (Figure 1B) and 
the circumflex branch. No other significant oc-
clusions of the coronary arteries were observed. 
We decided to perform revascularization in 
this patient due to resistance HFrEF to pharma-
cotherapy, recurrent chest pain episodes, and 
likely short LAD occlusion time (about 6 weeks 
history of chest pain episodes and dyspnea). 
The heart team recommended percutaneous 
revascularization which was performed the 
next day. Right radial access and the antegrade 
technique were used. The amplatz left guide 
catheter 6F provided adequate support, the 
LAD occlusion was crossed by guidewire Pilot 
50 (Figure 1C), balloon pre-dilatations were 
performed, and a new drug-eluting stent 
(3.5 × 40 mm) was implanted with a successful 
final result (Figure 1D). No recurrence of chest 
pain symptoms and reduction in the severity 
of heart failure symptoms were observed after 
this procedure. The patient was discharged as 
a COVID-19 convalescent. 
The rapidly progressing global COVID- 
-19 pandemic presents many difficulties for the 
functioning of health care systems [2, 3]. Data 
showed that in Poland the COVID-19 pandemic 
is associated with a large decline in the perfor-
mance of invasive cardiology procedures in the 
setting of the coronary syndrome [4]. Our case 
report shows that the SARS-CoV-2 infection of-
ten coexists with other chronic diseases, which 
may also be exacerbated. SARS-CoV-2 infection 
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should not delay treatment of HFrEF and coronary artery 
disease if the general condition of the patient allows for 
the required procedures [1, 5].
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Figure 1. Revascularization of  total occlusion of the left anterior descending artery. A. The left coronary artery angiogram. B. The right coro-
nary artery angiogram. C. Antegrade technique revascularization of the total occlusion. D. Final effect of the revascularization
Abbreviations: Cx, circumflex artery; DES, drug eluting stent in proximal left anterior descending artery; LAD, left anterior descending artery; 
LAD TO, total occlusion of proximal LAD; LM, left main; RCA, right coronary artery; W, coronary guidewire
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